Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Multicenter Observational Non-interventional Local Study on Prescription Behavior of Anticoagulation Therapy in Secondary Stroke Prevention in Atrial Fibrillation Patients

NCT01925755 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT01925755
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01925755 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Multicenter Observational Non-interventional Local Study on Prescription Behavior of Anticoagulation Therapy in Secondary Stroke Prevention in Atrial Fibrillation Patients
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
July 31, 2013
Completion date
July 31, 2015
Enrollment
209 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

embolism, stroke